-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Overweight on CVS Health, Raises Price Target to $106

Benzinga·05/14/2026 16:52:53
Listen to the news
Morgan Stanley analyst Erin Wright maintains CVS Health (NYSE:CVS) with a Overweight and raises the price target from $93 to $106.